Van Eck Associates Corp Grifols Sa Transaction History

Van Eck Associates Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$15.4 - $20.16 $7.07 Million - $9.25 Million	-459,025 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$18.24 - $21.45 $1.81 Million - $2.13 Million	99,418 Added 27.65%	459,025 $8.37 Million
Q1 2020 May 12, 2020	SELL	$16.28 - $25.63 $1.51 Million - $2.38 Million	-92,920 Reduced 20.53%	359,607 $7.24 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $603,851 - $725,733	30,856 Added 7.32%	452,527 $10.5 Million
Q3 2019 Nov 08, 2019	SELL	$19.85 - $22.76 $351,424 - $402,943	-17,704 Reduced 4.03%	421,671 $8.45 Million
Q2 2019 Aug 07, 2019	SELL	$17.59 - $21.1 $2.1 Million - $2.52 Million	-119,250 Reduced 21.35%	439,375 $9.27 Million
Q1 2019 May 13, 2019	SELL	$18.01 - $20.11 $509,250 - $568,630	-28,276 Reduced 4.82%	558,625 $11.2 Million
Q4 2018 Feb 12, 2019	SELL	$17.44 - $21.53 $97,594 - $120,481	-5,596 Reduced 0.94%	586,901 $10.8 Million
Q3 2018 Nov 13, 2018	BUY	$19.97 - $21.96 $325,870 - $358,343	16,318 Added 2.83%	592,497 $12.7 Million
Q2 2018 Aug 13, 2018	BUY	$20.16 - $24.68 $1.55 Million - $1.9 Million	77,105 Added 15.45%	576,179 $12.4 Million
Q1 2018 May 11, 2018	SELL	$20.31 - $24.95 $2.33 Million - $2.86 Million	-114,503 Reduced 18.66%	499,074 $10.6 Million
Q4 2017 Feb 12, 2018	SELL	$20.99 - $23.89 $6.38 Million - $7.26 Million	-304,099 Reduced 33.14%	613,577 $14.1 Million
Q3 2017 Nov 09, 2017	BUY	$20.07 - $21.89 $1.94 Million - $2.12 Million	96,869 Added 11.8%	917,676 $20.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	820,807	820,807 $17.3 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.